Foresite Capital

Activity in this selectionBiotech

By stage

Series A2

Series C+2

Series B1

Biotech5

United States5

5 in this selection

Aug 18

Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases

$66MSeries D

Role not disclosed

Aug 13

Develops oral small molecule therapies for immunological and chronic diseases

$50MSeries B

Role not disclosed

Feb 24

Advancing next-generation therapeutics for migraine and other headache disorders

$130MSeries A

Role not disclosed

Feb 18

Develops novel therapies to reduce the burden of neurodegenerative diseases

$175MSeries A

Role not disclosed

Jan 8

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries F

Role not disclosed